Financial statements Polpharm Consulting

Balance sheet of Polpharm Consulting

Company age:
Age:
4 y. 3 m. 23 d.
Share capital:
Share capital:
10 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of POLPHARM CONSULTING

Year
2021
2023
Total assets 379 085,83 378 767,87
A. Fixed assets 0,00 0,00
B. Current assets 373 985,83 378 767,87
C. Share capital contributions (basic funds) 5 100,00 0,00
D. Own shares (stocks) 0,00 0,00
Total liabilities 379 085,83 378 767,87
A. Equity 364 254,30 355 463,07
B. Liabilities and provisions for liabilities 14 831,53 23 304,80
I. Long-term liabilities 0,00 0,00
II. Short-term liabilities 14 831,53 23 304,80
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.